Intrasense wins CE mark for DUOnco Unity cancer CT follow-up AI tool

PUBT · 2d ago
Intrasense wins CE mark for DUOnco Unity cancer CT follow-up AI tool
  • Intrasense secured CE marking under EU MDR 2017/745 for DUOnco Unity, an AI tool supporting oncologic CT interpretation.
  • The software automates lesion detection, segmentation, and longitudinal tracking across thorax-abdomen-pelvis scans to standardize response assessment.
  • Development involved Guerbet, Gustave Roussy, and Angers University Hospital, with support from Bpifrance.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Intrasense SA published the original content used to generate this news brief on August 21, 2026, and is solely responsible for the information contained therein.